Fortress Biotech, Inc.
FBIONASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $61.36M
- P/E (TTM)
- 0.60
- Forward P/E
- 0.33
- Dividend yield
- -
- 52-week range
- $1.83$4.53
- Volume (live)
- -
- Avg. volume (3M)
- 265.00K
Fortress Biotech (FBIO) Stock Price & Financial Analysis
Fortress Biotech Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.91 - $1.99 |
|---|---|
| 52-Week High | $4.53 |
| 52-Week Low | $1.83 |
| Open | $1.98 |
| Volume (last close) | 223.62K |
| Average Volume (3M) | 265.00K |
| Revenue (TTM) | 66.91M |
|---|---|
| Net Income (TTM) | 102.03M |
| Free Cash Flow (TTM) | 119.41M |
| EPS (TTM) | $2.99 |
| Profit Margin | 152.48% |
| Operating Margin | -40.83% |
| Return on Equity (ROE) | 49.51% |
| Debt to Equity | 0.19 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 61.36M |
|---|---|
| Shares Outstanding | 31.79M |
| P/E Ratio (TTM) | 0.60 |
| Forward P/E | 0.33 |
| Price to Sales (P/S) | 0.92 |
| Price to Book (P/B) | 0.30 |
| EV/EBITDA | -0.71 |
| 50-Day MA | $2.45 |
|---|---|
| 200-Day MA | $2.87 |
| 1-Year Change | −21.03% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Fortress Biotech at a Glance
As of the Oct 23, 2026 close, Fortress Biotech (FBIO) has a market capitalization of $61.36M. The stock trades at 0.6× trailing earnings, 0.3× forward earnings and 0.9× sales. Over the trailing twelve months it earned $102.03M on revenue of $66.91M (a 152.5% profit margin) and generated $119.41M of free cash flow. Revenue grew 7.4% year over year.
As of its latest reported balance sheet, it holds $196.58M in cash and securities against $39.60M of debt, a net cash position of $156.97M.
Fortress Biotech does not currently pay a dividend.
The share price is down 21.0% over the past year. At $1.93 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $1.83 to $4.53, below its 200-day moving average of $2.87.
Frequently Asked Questions About Fortress Biotech
What is the current stock price for FBIO?
As of the Oct 23, 2026 close, FBIO stock trades at $1.93. The 52-week range is $1.83–$4.53, with a day range of $1.91–$1.99.
What is the P/E ratio for FBIO?
As of the Oct 23, 2026 close, Fortress Biotech's trailing twelve-month (TTM) P/E ratio is 0.6, meaning investors pay $0.6 for every $1 of annual earnings. The forward P/E is 0.3, reflecting analyst expectations for future earnings. Fortress Biotech operates in the Healthcare sector.
Does FBIO pay dividends?
Fortress Biotech does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for FBIO?
Analyst ratings and recommendations for FBIO are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of FBIO?
As of the Oct 23, 2026 close, Fortress Biotech's market capitalization is $61.4M, classifying it as a micro-cap company. Fortress Biotech operates in the Healthcare sector within the Biotechnology industry.